dcsimg

EMIR white papers

Found  11 white papers and resources

Emir

Display results per page

Bloomberg Ready to Support Buy-side in Valuation & Collateral Reporting under EMIR

Company: Bloomberg

Back in February this year, buy-side institutions and their bank counterparts were required to start reporting derivative trades and positions under EMIR (European Market Infrastructure Regulation). Bloomberg moved quickly to provide its EMIR reporting solution under this first phase and is already VIEW SUMMARY

Category: EMIR | Published: 15 September 2014 | Type: White Paper

Rating: + 1

EMIR Special Report August 2014

Company: Bloomberg

This special report explores lessons learned from the first EMIR reporting phase, which became effective on Feb. 12, and looks forward to the newest phase, exploring what the newly reported data will tell regulators about the bigger picture of the derivatives market in the European Union. We also VIEW SUMMARY

Category: EMIR | Published: 08 September 2014 | Type: White Paper

Rating: + 3

GRC Maturity: From Disorganized to Integrated Risk and Performance

Company: IBM Business Analytics

Success in today’s dynamic business environment requires organizations to integrate, build and support business processes with an enterprise view of governance, risk management and compliance (GRC). Without an integrated view of risk and compliance, the scattered and nonintegrated approaches of the VIEW SUMMARY

Category: Compliance | Published: 14 August 2014 | Type: White Paper

Rating: + 9

Global Anti-Money Laundering Survey 2014

Company: KPMG

It is 10 years since we released our first Global Anti-Money Laundering (AML) survey. During those 10 years, financial institutions have ridden the highs, and plunged to the lows, of the economic cycle. Despite these dramatic changes in the business environment, AML has remained a key focus area VIEW SUMMARY

Category: Compliance | Published: 09 July 2014 | Type: White Paper

Rating: + 7

Collateral management survey 2013

Company: BNY Mellon

Insurance Risk’s second collateral management survey in conjunction with BNY Mellon finds more insurers are taking steps to prepare for new derivatives regulation, but concerns about collateral availability are mounting VIEW SUMMARY

Category: Credit Derivatives | Published: 19 November 2013 | Type: White Paper

Rating: + 20

Enhancing the value chain: how to thrive in an uncertain world

Company: Misys

Asset managers are under enormous pressure to operate effectively in today’s New Normal environment. A number of dynamic headwinds have to be overcome if they are to succeed and stand out from the competition. VIEW SUMMARY

Category: Operational Risk | Published: 03 September 2013 | Type: White Paper

Rating: + 1

Turning Reform into Competitive Advantage

Company: OpenLink

As Europe embraces a new era of cleared and executed derivatives VIEW SUMMARY

Category: EMIR | Published: 22 August 2013 | Type: White Paper

Rating: + 5

EMIR: illustrative implementation timeline – update

Company: Clifford Chance

Obligations concerning derivatives reforms under the EU regulation on OTC derivatives, central counterparties and trade repositories (European Markets Infrastructure Regulation, 'EMIR') is summarised in this handy illustrative timeline. VIEW SUMMARY

Category: EMIR | Published: 15 May 2013 | Type: White Paper

Rating: + 5

EMIR - what are the margin requirements for uncleared OTC derivatives?

Company: Reed Smith

Much of EMIR is now coming more clearly into focus. But a major unknown has for a long time been the question of margin requirements for uncleared OTC derivatives. BCBS/IOSCO has published its second consultation paper. This white paper considers the implications of these near finalised proposals. VIEW SUMMARY

Category: EMIR | Published: 21 February 2013 | Type: White Paper

Rating: + 5

European Parliament withdraws objection to EMIR technical standards

Company: Herbert Smith Freehills LLP

The EC recently withdrew its objection to legislation adopted by the European Commission for technical standards on OTC derivatives, central counterparties and trade depositories. The reasons for the objections, how the compromise was agreed and what this means for the finance industry is reviewed. VIEW SUMMARY

Category: EMIR | Published: 11 February 2013 | Type: White Paper

Display results per page

As a member you receive free access to our constantly updated library of white papers, analyst reports, web casts and legal briefings.

  • Stay informed
  • Compare services
  • Save documents
  • Receive email alerts

As a member you receive free access to our constantly updated library of white papers, analyst reports, web casts and legal briefings.

Categories related to EMIR